9.1 Glycolysis: The Ten Steps, Regulation & Anaerobic Fermentation

Key Takeaways

  • Glycolysis operates in the cytosol across 10 enzymatic reactions, consuming 2 ATP in the preparatory investment phase (Hexokinase and PFK-1) and yielding 4 ATP via substrate-level phosphorylation (PGK and Pyruvate Kinase) and 2 NADH (GAPDH), for a net output of 2 pyruvate, 2 ATP, and 2 NADH per glucose.

  • The three irreversible glycolytic checkpoints are Hexokinase/Glucokinase, Phosphofructokinase-1 (PFK-1, committed rate-limiting step), and Pyruvate Kinase; PFK-1 is allosterically regulated by cellular energy charge (ATP, AMP, citrate) and fructose-2,6-bisphosphate (F-2,6-BP), whose hepatic concentration is controlled by insulin/glucagon phosphorylation of the bifunctional enzyme PFK-2/FBPase-2.

  • Under anaerobic conditions or in erythrocytes lacking mitochondria, Lactate Dehydrogenase reduces pyruvate to lactate, oxidizing NADH back to NAD+ to sustain the essential substrate pool for Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH).

Last updated: September 2026

9.1 Glycolysis: The Ten Steps, Regulation & Anaerobic Fermentation

Note

Foundational Standard: Cellular metabolism on the MCAT evaluates the flow of carbon backbones, bioenergetic stoichiometry (ATP and reduced electron carriers), and allosteric and endocrine regulatory switches. Mastery of cytosolic carbohydrate handling requires tracking the thermodynamic barriers separating catabolic breakdown from anabolic resynthesis.

All eukaryotic cells extract metabolic energy from glucose through cytosolic glycolysis. Depending on tissue identity, hormonal status, and cellular energy charge, glucose can be completely oxidized to pyruvate, conserved via hepatic gluconeogenesis, or shunted into the pentose phosphate pathway to supply reducing equivalents and nucleotide precursors.


The Ten Steps of Glycolysis: Investment and Payoff Phases

Glycolysis converts one six-carbon molecule of glucose into two three-carbon molecules of pyruvate entirely within the cytosol, requiring no molecular oxygen (O2O_2). The pathway comprises two distinct bioenergetic stages:

The Energy Investment (Preparatory) Phase (Steps 1–5)

The investment phase activates the hexose ring by consuming two high-energy ATP molecules, trapping sugar intermediates inside the cell and priming the carbon skeleton for cleavage into two triose phosphates.

  1. Hexose Phosphorylation (Step 1): Glucose is phosphorylated at C6 to yield glucose-6-phosphate (G6P), coupling the reaction to exergonic ATP hydrolysis (ΔG∘′=−16.7 kJ/mol\Delta G^{\circ\prime} = -16.7\text{ kJ/mol}). Because phosphorylated sugars lack transmembrane transport proteins, this step irreversibly traps glucose inside the cytosol.
    • Hexokinase (Isozymes I–III): Expressed in virtually all peripheral tissues. Characterized by a very low KmK_m (≈0.1 mM\approx 0.1\text{ mM}), operating near maximal velocity even during fasting hypoglycemia. Strongly feedback-inhibited by its product, G6P.
    • Glucokinase (Hexokinase IV): Expressed exclusively in hepatocytes and pancreatic β\beta-cells. Possesses a high KmK_m (≈10 mM\approx 10\text{ mM}) and a sigmoidal kinetics profile, functioning as a physiological glucose sensor. Glucokinase is not inhibited by G6P and is transcriptionally induced by insulin, enabling the liver to clear large glucose surges following carbohydrate-rich meals.
  2. Phosphoglucose Isomerization (Step 2): Phosphoglucose Isomerase (PGI) converts glucose-6-phosphate (an aldose) into fructose-6-phosphate (F6P) (a ketose). This reversible isomerization repositions the carbonyl oxygen to C2, setting up the subsequent phosphorylation at C1.
  3. The Committed Phosphorylation (Step 3): Phosphofructokinase-1 (PFK-1) transfers a phosphoryl group from ATP to C1 of F6P, producing fructose-1,6-bisphosphate (F-1,6-BP) (ΔG∘′=−14.2 kJ/mol\Delta G^{\circ\prime} = -14.2\text{ kJ/mol}). This is the primary rate-limiting, committed step of glycolysis.
  4. Aldol Cleavage (Step 4): Aldolase cleaves the six-carbon F-1,6-BP into two distinct phosphorylated trioses: the ketose dihydroxyacetone phosphate (DHAP) and the aldose glyceraldehyde-3-phosphate (GAP).
  5. Triose Isomerization (Step 5): Triose Phosphate Isomerase (TPI) rapidly and reversibly interconverts DHAP and GAP. Because GAP is continuously consumed by Step 6, Le Chatelier's principle drives total conversion of DHAP into GAP. Thus, each starting glucose yields two molecules of GAP entering the payoff phase.

The Energy Payoff Phase (Steps 6–10)

The payoff phase operates twice per initial glucose molecule, harvesting metabolic energy to generate 4 ATP and 2 NADH.

  1. Oxidation & Phosphorylation (Step 6): Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) catalyzes the simultaneous oxidation and phosphorylation of GAP using inorganic phosphate (Pi\text{P}_i) and NAD+\text{NAD}^+, forming 1,3-bisphosphoglycerate (1,3-BPG) and NADH + H+\text{H}^+. The high-energy mixed anhydride bond at C1 holds sufficient standard free energy of hydrolysis (ΔG∘′=−49.4 kJ/mol\Delta G^{\circ\prime} = -49.4\text{ kJ/mol}) to drive subsequent substrate-level phosphorylation.
  2. First Substrate-Level Phosphorylation (Step 7): Phosphoglycerate Kinase (PGK) transfers the high-energy C1 phosphate of 1,3-BPG to ADP, generating ATP and 3-phosphoglycerate (3-PG). Across both trioses, this yields 2 ATP, repaying the initial 2 ATP invested in Steps 1 and 3.
  3. Phosphoryl Shift (Step 8): Phosphoglycerate Mutase (PGM) isomerizes 3-PG to 2-phosphoglycerate (2-PG) via a 2,3-bisphosphoglycerate intermediate, relocating the phosphate closer to the carboxylic acid.
  4. Dehydration (Step 9): Enolase removes a water molecule from 2-PG, introducing a high-energy enol-phosphate ester bond to form phosphoenolpyruvate (PEP). PEP possesses the highest phosphate-transfer potential of any physiological metabolite (ΔG∘′=−61.9 kJ/mol\Delta G^{\circ\prime} = -61.9\text{ kJ/mol}).
  5. Second Substrate-Level Phosphorylation (Step 10): Pyruvate Kinase (PK) transfers the phosphate from PEP to ADP, generating pyruvate and ATP (ΔG∘′=−31.4 kJ/mol\Delta G^{\circ\prime} = -31.4\text{ kJ/mol}). Pyruvate kinase is allosterically activated by feedforward stimulation from fructose-1,6-bisphosphate, ensuring that intermediate influx coordinates with terminal payoff.

Net Stoichiometric Balance Sheet

Glucose+2 NAD++2 ADP+2 Pi⟶2 Pyruvate+2 NADH+2 H++2 ATP+2 H2O\text{Glucose} + 2\text{ NAD}^+ + 2\text{ ADP} + 2\text{ P}_i \longrightarrow 2\text{ Pyruvate} + 2\text{ NADH} + 2\text{ H}^+ + 2\text{ ATP} + 2\text{ H}_2\text{O}

Allosteric & Hormonal Regulation: The PFK-1 / PFK-2 Regulatory Switch

Flux through glycolysis is tightly coupled to cellular energy charge and systemic endocrine cues. Because Step 3 is irreversible and commits hexoses irrevocably to catabolism, PFK-1 is the focal control hub.

Allosteric Modulators of PFK-1

  • Inhibitors (High Energy Charge / Surplus Intermediates):
    • ATP: Operates as both a substrate at the catalytic site and an allosteric inhibitor at a distinct regulatory site. When [ATP] is high, it binds the allosteric site, lowering PFK-1's affinity for F6P.
    • Citrate: A downstream TCA cycle intermediate. Elevated cytosolic citrate signals sufficient biosynthetic precursors and Krebs cycle saturation, potently enhancing ATP's inhibitory effect on PFK-1.
  • Activators (Low Energy Charge):
    • AMP / ADP: High [AMP] signals severe adenylate depletion, displacing ATP from the inhibitory site and shifting PFK-1 into the active, high-affinity R-state.
    • Fructose-2,6-Bisphosphate (F-2,6-BP): The most potent physiological activator of PFK-1. It overrides high ATP inhibition, driving glycolysis even when cellular ATP levels are robust.

The Bifunctional PFK-2 / FBPase-2 Enzyme

Fructose-2,6-bisphosphate is not an intermediate of glycolysis; it is a dedicated signaling molecule synthesized and degraded by a single bifunctional homodimeric enzyme possessing two opposing catalytic domains:

  • Phosphofructokinase-2 (PFK-2) Domain: Synthesizes F-2,6-BP from F6P and ATP.
  • Fructose-Bisphosphatase-2 (FBPase-2) Domain: Hydrolyzes F-2,6-BP back to F6P and Pi\text{P}_i.

In hepatocytes, the balance between these two domains is controlled by cAMP-dependent protein kinase (PKA) in response to pancreatic hormones:

  • Fasting / Glucagon Dominance: Glucagon binds GsG_s-protein coupled receptors, elevating cAMP and activating PKA. PKA phosphorylates the hepatic bifunctional enzyme. Phosphorylation inhibits the PFK-2 domain and activates the FBPase-2 domain. Intracellular [F-2,6-BP] drops precipitously. The release of PFK-1 activation halts glycolysis, while the loss of F-1,6-bisphosphatase inhibition unleashes gluconeogenesis.
  • Fed / Insulin Dominance: Insulin triggers Protein Phosphatase 1 (PP1), which dephosphorylates the bifunctional enzyme. Dephosphorylation activates the PFK-2 domain and inactivates the FBPase-2 domain. Rising [F-2,6-BP] potently stimulates PFK-1, accelerating glycolytic throughput to process dietary carbohydrates.

Anaerobic Fermentation: Lactate Dehydrogenase & NAD+ Regeneration

Under aerobic conditions, the 2 NADH generated by GAPDH in Step 6 deliver their electrons to the mitochondrial electron transport chain via cytosolic shuttle systems, regenerating NAD+\text{NAD}^+. However, under anaerobic conditions (hypoxic skeletal muscle) or in cells devoid of mitochondria (mature red blood cells), the electron transport chain cannot oxidize NADH.

Without a mechanism to regenerate NAD+\text{NAD}^+, cytosolic pools of NAD+\text{NAD}^+ would be rapidly depleted, arresting glycolysis at Step 6 and causing cellular death from ATP starvation.

The Lactate Dehydrogenase (LDH) Reaction

Pyruvate+NADH+H+⇌Lactate DehydrogenaseL-Lactate+NAD+\text{Pyruvate} + \text{NADH} + \text{H}^+ \xrightleftharpoons{\text{Lactate Dehydrogenase}} \text{L-Lactate} + \text{NAD}^+

LDH reduces pyruvate to lactate, transferring two electrons and a proton from NADH to regenerate the cytosolic NAD+\text{NAD}^+ pool. This allows GAPDH to continue functioning, enabling persistent anaerobic ATP generation (2 net ATP per glucose).

The Cori Cycle

Lactate produced by actively contracting muscle or erythrocytes cannot be metabolized further in situ. It is extruded into the blood and carried to the liver. Hepatocytes take up lactate, re-oxidize it to pyruvate via hepatic LDH (favored by low cytosolic [NADH]/[NAD+\text{NAD}^+]), and convert pyruvate back into glucose via gluconeogenesis. The regenerated glucose is secreted into the bloodstream, completing the Cori cycle.

Loading diagram...
Reciprocal Regulation of Glycolysis and Gluconeogenesis via PFK-1 and FBPase-1
Test Your Knowledge

A hepatocyte is exposed to a high circulating glucagon concentration during fasting. Glucagon raises intracellular cAMP, which activates protein kinase A and leads to phosphorylation of the bifunctional enzyme PFK-2/FBPase-2. What is the direct consequence for glycolytic flux in that hepatocyte?

A

Fructose-2,6-bisphosphate concentration falls, removing allosteric activation of phosphofructokinase-1 and slowing glycolysis

B

Fructose-2,6-bisphosphate concentration rises, allosterically activating phosphofructokinase-1 and accelerating glycolysis

C

Fructose-1,6-bisphosphate is converted directly to glucose-6-phosphate, bypassing phosphofructokinase-1 entirely

D

Hexokinase is allosterically activated by its own product, increasing glucose trapping and accelerating glycolysis

Sections you finish are checked off in the contents.